[Serotypes and antibiotic sensitivity of hemolytic streptococci isolated from clinical specimens in Hiroshima Prefecture, 1987-1989].
The grouping, the typing and the drug-sensibility of hemolytic streptococci isolated from the clinical specimens taken from 4 medical centers in Hiroshima Prefecture have been examined and reviewed during the past 3 years 1987-1989. The results were summarized in this report. 1. Of 1572 strains of hemolytic streptococci, 844 strains (53.7%) were group A; 539 strains (34.3%), group B; 14 strains (0.9%), group C; 82 strains (5.2%), group G; and 93 strains (5.9%), the others. We found that group A and group B were predominant, and the incidence rate of group B was higher than it used to be. 2. The prevalent types were T-4 (37.9%), T-1 (13.6%), T-12 (12.0%), and T-28 (10.7%) in group A, while Ia (26.2%), M9 (provisional type 18.4%), and III (14.5%) in group B. 3. As far as the detection data of each month is concluded, during the summer season we could hardly detect group A which peak of occurrence during the winter season. These findings were really consistent with the occurrence pattern of those patients who suffered from streptococcal infectious disease. But this occurrence pattern couldn't be found in group B. 4. In our study, the positive frequency was throat swab greater than urine greater than sputum greater than vaginal swab greater than pus greater than ear secretion in order. Group A was mainly isolated from throat swab, while group B, from several specimens including urine. 5. We found that there was a high drug-sensibility to the beta-lactam drugs in all strains except for 3 strains of group B which were resistant to CEX.(ABSTRACT TRUNCATED AT 250 WORDS)
Hiroshima Prefectural Institute of Public Health.
M
M
Sakaki
H
H
Doi
M
M
Kuwabara
J
J
Yamada
Y
Y
Kashiwagi
M
M
Endo
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D007564:Japan / Q000453:epidemiology; D007769:Lactams; D008826:Microbial Sensitivity Tests; D010614:Pharynx / Q000382:microbiology; D012703:Serotyping; D013290:Streptococcal Infections / Q000453:epidemiology / Q000382:microbiology; D013291:Streptococcus / Q000145:classification* / Q000187:drug effects / Q000302:isolation & purification; D013292:Streptococcus agalactiae / Q000187:drug effects; D013297:Streptococcus pyogenes / Q000187:drug effects; D014556:Urine / Q000382:microbiology
D000900:Anti-Bacterial Agents; D007769:Lactams